Interestingly, CD45RO−CD62L+- and CD45RO+CD62L+ Tcyt frequencies in COVID-19 survivors were significantly higher than in the patients with a poor outcome in the acute stage of the disease (Figure 2E,F). Here, SELL is linked to COVID-19.